CI

Circumvent

YC S18 ↗

Portland, US · 6 employees · 1 known investors

circumventpharmaceuticals.com ↗

Circumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders. The company's research targets synaptic dysfunction and lysosomal pathways through investigation of the palmitoylome.

Founders & leadership· Y Combinator alumni (S18)

DW

Devin WileyinFounder

Investors · 1

Y

Y CombinatorSan Francisco · $500K